Intellectual Property India Publishes Patent Application for 'Antibody Resistant Modified Receptors To Enhance Cell-Based Therapies' Filed by Regeneron Pharmaceuticals, Inc.

MUMBAI, India, May 2 -- Intellectual Property India has published a patent application (202517037750 A) filed by Regeneron Pharmaceuticals, Inc., Tarrytown, U.S.A., on April 18, for 'antibody resistant modified receptors to enhance cell-based therapies.'

Inventor(s) include Moore, Michael; Panea, Casandra; Sleeman, Matthew; Murphy, Andrew J.; Yancopoulos, George D.; Zhang, Liang; and Romero Hernandez, Annabel.

The application for the patent was published on May 2, under issue no. 18/2025.

According to the abstract released by the Intellectual Property India: "Methods for improving engraftment of donor cells in a subject thereof are provided. Such methods can comprise providing donor cells that have been modified to express a first isofor...